SU‐GG‐J‐52: Inclusion of KV CBCT Dose in the Patient Treatment Plans and Evaluation of Dose to Normal Tissue and Critical Organs

P. Alaei, E. Spezi, P. Downes, R. Jarvis, E. Radu, M. Reynolds

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'SU‐GG‐J‐52: Inclusion of KV CBCT Dose in the Patient Treatment Plans and Evaluation of Dose to Normal Tissue and Critical Organs'. Together they form a unique fingerprint.

Medicine & Life Sciences